Format

Send to

Choose Destination
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):165-168. doi: 10.1002/ccd.26522. Epub 2016 May 14.

Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.

Author information

1
University of Washington, Division of Cardiology, Box 356422, Seattle, WA 98195-6422.

Abstract

Thrombotic aortic valve restenosis following transcatheter aortic valve replacement (TAVR) has not been extensively reported and the rates of TAVR valve thrombosis are not known. We present three cases of valve-in-valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation.

KEYWORDS:

anticoagulants/antithrombins; antiplatelet therapy; aortic valve disease; percutaneous intervention; percutaneous valve therapy; structural heart disease intervention; transcatheter valve implantation

PMID:
27198960
DOI:
10.1002/ccd.26522

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center